Institutions / Danske Bank A/S / Activity
Activity — Danske Bank A/S
6,031 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q4 2024 as of | Exit | 812215101 Common stock | $0 | -1 -100.00% | 0 | low |
| Q3 2024 as of | New | 92337U203 Common stock | $0 | +2 | 2 0.00% of portfolio | low |
| Q2 2024 as of | New | Kiniksa Pharmaceuticals International, plc Common stock | $0 | +923 | 923 0.00% of portfolio | low |
| Q3 2024 as of | New | 812215101 Common stock | $0 | +1 | 1 0.00% of portfolio | low |
| Q3 2024 as of | New | 09175M507 Common stock | $0 | +2 | 2 0.00% of portfolio | low |
| Q2 2024 as of | Trim | Nebius Group N.V. Common stock | $0 | -58K -37.75% | 95,184 0.00% of portfolio | low |
| Q4 2024 as of | Exit | 09175M507 Common stock | $0 | -2 -100.00% | 0 | low |
| Q4 2024 as of | Exit | 92337U203 Common stock | $0 | -2 -100.00% | 0 | low |
| Q4 2025 as of | Exit | 18978H300 Common stock | $0 | -2 -100.00% | 0 | low |
| Q3 2024 as of | New | 00808Y406 Common stock | $0 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | Exit | 98423K108 Common stock | $0 | -6 -100.00% | 0 | low |
| Q3 2024 as of | New | 18978H300 Common stock | $0 | +2 | 2 0.00% of portfolio | low |
| Q4 2024 as of | Exit | 29273B401 Common stock | $-1 | -3 -100.00% | 0 | low |
| Q4 2024 as of | Exit | 90137F301 Common stock | $-1 | -3 -100.00% | 0 | low |
| Q4 2024 as of | Exit | 60879E200 Common stock | $-1 | -3 -100.00% | 0 | low |
| Q3 2024 as of | New | 90137F301 Common stock | $1 | +3 | 3 0.00% of portfolio | low |
| Q3 2024 as of | New | 29273B401 Common stock | $1 | +3 | 3 0.00% of portfolio | low |
| Q3 2024 as of | New | 60879E200 Common stock | $1 | +3 | 3 0.00% of portfolio | low |
| Q4 2025 as of | Exit | 03815U409 Common stock | $-1 | -3 -100.00% | 0 | low |
| Q4 2025 as of | New | Biovie Inc. Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | New | NOTE FiscalNote Holdings, Inc. Common Stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | Exit | 42237K508 Common stock | $-1 | -4 -100.00% | 0 | low |
| Q3 2024 as of | New | 45339J105 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q3 2024 as of | New | 68236P206 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q3 2024 as of | New | 961884202 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2024 as of | Exit | G0360L134 Common stock | $-1 | -1 -100.00% | 0 | low |
| Q4 2025 as of | New | 36117V303 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2024 as of | Exit | 92864V400 Common stock | $-1 | -1 -100.00% | 0 | low |
| Q3 2024 as of | New | 00653A107 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | Exit | 00653A107 Common stock | $-1 | -1 -100.00% | 0 | low |
| Q3 2024 as of | New | 92864V400 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q3 2024 as of | New | VANI Vivani Medical, Inc. Common Stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | New | AEON AEON Biopharma, Inc. Common Stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q3 2024 as of | New | LUCD Lucid Diagnostics Inc. Common Stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | Exit | 00808Y406 Common stock | $-1 | -1 -100.00% | 0 | low |
| Q3 2024 as of | New | 02115D208 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q3 2024 as of | New | American Battery Technology Co Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | New | 54570M306 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | New | 76135L705 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2024 as of | Exit | 89357L303 Common stock | $-1 | -2 -100.00% | 0 | low |
| Q3 2024 as of | New | AWHL Aspira Women's Health Inc. Common Stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | Exit | 78418A604 Common stock | $-1 | -2 -100.00% | 0 | low |
| Q3 2024 as of | New | 89357L303 Common stock | $1 | +2 | 2 0.00% of portfolio | low |
| Q3 2024 as of | New | ATHE Alterity Therapeutics Ltd ADR | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2024 as of | Exit | 83013Q806 Common stock | $-1 | -1 -100.00% | 0 | low |
| Q4 2025 as of | New | USBC USBC, Inc. Common Stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | New | 79400X503 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q4 2024 as of | Exit | 78637J105 Common stock | $-1 | -2 -100.00% | 0 | low |
| Q3 2024 as of | New | 87166L209 Common stock | $1 | +1 | 1 0.00% of portfolio | low |
| Q3 2024 as of | New | TOVX Theriva Biologics, Inc. Common Stock | $1 | +1 | 1 0.00% of portfolio | low |